MedTrace Logo

Repetitive Transcranial Magnetic Stimulation (rTMS) in MS Induced Spastic Paraparesis

NCT07159789 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-04

No results posted yet for this study

Summary

Study the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.

Conditions

Interventions

DEVICE

Repetitive Transcranial Magnetic Stimulation

Treatment with the rTMS or sham rTMS will be scheduled daily 5x per week for a total of 6 consecutive weeks followed, after a 6 week pause, by another treatment session of 6 weeks where all patients will receive active rTMS treatment

Sponsors & Collaborators

  • University of Ottawa

    collaborator OTHER

  • Clinique Neuro-Outaouais

    lead OTHER

Principal Investigators

  • Francois Jacques, Neurologist · Clinique Neuro-Outaouais

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-15
Primary Completion
2027-10-31
Completion
2028-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07159789 on ClinicalTrials.gov